Industry Symposium

New therapeutic options
Chairperson: Konstantinos Kostikas (GR)

Asthma management: which patients are suitable for triple therapy
Arzu Yorgancioglu (TR)

COPD management: beyond exacerbations
Nikolaos Tzanakis (GR)

Industry Symposium

Τiotropium and pirfenidone on chronic lung disease outcomes
Chairperson: Konstantinos Kostikas (GR)
Commentator: Stavros Tryfon (GR)

The value of tiotropium in the treatment of COPD: RETRIEVE study
Christos Kyriakopoulos (GR)

Early diagnosis and therapeutic approach in idiopathic pulmonary fibrosis: Does it matter?
Athena Gogali (GR)

Industry Speech
Chairperson: Konstantinos Kostikas (GR)

Dual bronchodilation in the management of COPD: Key Learnings from GOLD 2023
Dave Singh (UK)

Industry Symposium

Evolving the knowledge on COPD and Severe Asthma management for optimized patient outcomes
Chairperson: Stylianos Loukides (GR)

18.30-18.50 The puzzle of severe asthma treatment
Andrew Menzies-Gow (UK)

8.50-19.10 Delivering Budesonide/ Glycopyrronium/ Formoterol through AEROSPHERE Delivery Technology
Omar Usmani (UK)

19.10-19.15 Q&A

Industry Symposium
Optimizing the journey for the respiratory patients: from prevention to remission
Chairperson: Konstantinos Kostikas (GR)

19:15-19:35: Unravelling the impact of RSV: the value of prevention
Nikolaos Tzanakis (GR)

19:35-19:55: The pivotal role of IL5 in T2 high inflammation of severe asthma
Georgios Hillas (GR)

19:55-20:00 Q&A

Industry Symposium
Optimizing Asthma & COPD management
Chairperson: Konstantinos Kostikas (GR)

Focusing on Asthma Control
Michalis P. Vaias (GR)

COPD management in the era of triple therapy.
Georgios Hillas (GR)

Industry Speech

Chairperson: Stylianos Loukides (GR)

The importance of a fixed dosage regimen in asthma control
Eleftherios Zervas (GR)

Industry Symposium
Chairperson: Konstantinos Kostikas (GR)

13:00-13:20 PCV20: The strategy for a comprehensive pneumococcal vaccination (20 min)
Paraskevi Katsaounou (GR)

13:20-13:40 COVID-19 outpatient treatment: the role of nirmatrelvir/ritonavir (20 min)
Petros Bakakos (GR)

13:40-14:00 Ceftazidime-avibactam in treatment of MDR Gram-negative infections (20 min)
Nikoletta Rovina (GR)

14:00-14:15 Discussion

Industry Speech
Chairperson: Konstantinos Kostikas (GR)

Managing patients with pulmonary fibrosis in daily clinical practice
Ilias Papanikolaou (GR)